Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 24    symbols : MRTX    save search
Mirati Therapeutics' Adagrasib Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Patients with Advanced Non-Small Cell Lung Cancer Harboring the KRAS G12C Mutation
Published: 2021-06-24 (Crawled : 21:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0 twitter stocktwits trandingview |
Health Technology
 | | O: 1.24% H: 3.82% C: -0.12%
food lung cancer therapy cancer breakthrough therapy drug designation
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services
INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology
ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology
GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.